Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
What is the purpose of this trial?
The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.
- N/A - N/A
- Spectrum Pharmaceuticals, Inc
- February 2010
- Last Updated:
- February 5, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT01110733